BioMarin Pharmaceutical Inc. (BMRN) Stock

BioMarin Pharmaceutical Inc. (BMRN) is a Healthcare stock trading at $54.70 (as of 2026-06-18), with a market capitalization of $10.31B and a trailing P/E of 40.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

BioMarin Pharmaceutical Inc. develops and markets treatments for people with serious, life-threatening rare diseases and medical conditions. Its products include therapies such as enzyme replacement and related approaches for disorders including MPS IV, MPS VI, ceroid lipofuscinosis type 2, and phenylketonuria, along with treatments for achondroplasia and other targeted indications.

Valuation — source: SEC EDGAR (first-party)
Price$54.70
Market Cap$10.31B
P/E Ratio40.3
EV / EBITDA23.6
Price / Book1.74
Price / Sales3.34
DCF Value (model)$101.93
DCF Upside vs Price86.4%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$3.22B
Net Margin10.8%
Return on Equity4.3%
Debt / Equity0.23
Current Ratio5.81
Revenue Growth (YoY)2.8%
EPS Growth (YoY)-43.3%
FCF Growth (YoY)26.7%
Financial Health — source: SEC EDGAR
Altman Z-Score5.32 (safe)
Valuation vs Sector & Industry
Stock P/E40.3
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector92.0%
vs Industry133.2%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock, Inc. ($1.12B)
Institutional Holders Tracked10
Congressional Trades (recent)1
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOAlexander Hardy
Employees3,040
CountryUS
IPO Date1999-07-26

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Madrigal Pharmaceuticals, Inc. (MDGL)
  • Ionis Pharmaceuticals, Inc. (IONS)
  • Moderna, Inc. (MRNA)
  • Exelixis, Inc. (EXEL)
  • Radiopharm Theranostics Limited (RADX)
  • Elanco Animal Health Incorporated (ELAN)
  • Jazz Pharmaceuticals plc (JAZZ)
  • Qiagen N.V. (QGEN)
BMRN earnings history · BMRN institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.